73 related articles for article (PubMed ID: 21715128)
21. Clinical usefulness of mitochondrial transcription factor A expression as a predictive marker in colorectal cancer patients treated with FOLFOX.
Yoshida Y; Hasegawa J; Nezu R; Kim YK; Hirota M; Kawano K; Izumi H; Kohno K
Cancer Sci; 2011 Mar; 102(3):578-82. PubMed ID: 21205083
[TBL] [Abstract][Full Text] [Related]
22. Serum IGF-I, IGFBP-3, and matrix metalloproteinase-7 levels and acquired chemo-resistance in advanced colorectal cancer.
Gallego R; Codony-Servat J; García-Albéniz X; Carcereny E; Longarón R; Oliveras A; Tosca M; Augé JM; Gascón P; Maurel J
Endocr Relat Cancer; 2009 Mar; 16(1):311-7. PubMed ID: 19109398
[TBL] [Abstract][Full Text] [Related]
23. Preoperative C-reactive protein as a prognostic and therapeutic marker for colorectal cancer.
Koike Y; Miki C; Okugawa Y; Yokoe T; Toiyama Y; Tanaka K; Inoue Y; Kusunoki M
J Surg Oncol; 2008 Dec; 98(7):540-4. PubMed ID: 18937231
[TBL] [Abstract][Full Text] [Related]
24. The efficacy and toxicity of FOLFOX regimen (a combination of leucovorin and fluorouracil with oxaliplatin) as first-line treatment of metastatic colorectal cancer.
Matsushita H; Tsuboi K; Honda I; Kato N; Okochi O; Kobayashi D; Hattori M
Gan To Kagaku Ryoho; 2009 May; 36(5):797-801. PubMed ID: 19461180
[TBL] [Abstract][Full Text] [Related]
25. Oxidative stress in non-small cell lung cancer patients after chemotherapy: association with treatment response.
Gupta A; Srivastava S; Prasad R; Natu SM; Mittal B; Negi MP; Srivastava AN
Respirology; 2010 Feb; 15(2):349-56. PubMed ID: 20199646
[TBL] [Abstract][Full Text] [Related]
26. Effect of chemotherapy on serum end-products of lipid peroxidation in patients with small cell lung cancer: association with treatment results.
Nowak D; Janczak M
Respir Med; 2006 Jan; 100(1):157-66. PubMed ID: 15890507
[TBL] [Abstract][Full Text] [Related]
27. Adenosine deaminase enzyme activity is increased and negatively correlates with catalase, superoxide dismutase and glutathione peroxidase in patients with Behçet's disease: original contributions/clinical and laboratory investigations.
Erkiliç K; Evereklioglu C; Cekmen M; Ozkiris A; Duygulu F; Dogan H
Mediators Inflamm; 2003 Apr; 12(2):107-16. PubMed ID: 12775361
[TBL] [Abstract][Full Text] [Related]
28. [FOLFOX as adjuvant chemotherapy after curative resection of distant metastatic lesions in patients with colorectal cancer].
Nozawa H; Kitayama J; Sunami E; Saito S; Kanazawa T; Kazama S; Yazawa K; Kawai K; Mori K; Nagawa H
Gan To Kagaku Ryoho; 2011 Oct; 38(10):1627-32. PubMed ID: 21996957
[TBL] [Abstract][Full Text] [Related]
29. Influence of uric acid and gamma-glutamyltransferase on total antioxidant capacity and oxidative stress in patients with metabolic syndrome.
Simão AN; Dichi JB; Barbosa DS; Cecchini R; Dichi I
Nutrition; 2008; 24(7-8):675-81. PubMed ID: 18499396
[TBL] [Abstract][Full Text] [Related]
30. OPTIMOX1: a randomized study of FOLFOX4 or FOLFOX7 with oxaliplatin in a stop-and-Go fashion in advanced colorectal cancer--a GERCOR study.
Tournigand C; Cervantes A; Figer A; Lledo G; Flesch M; Buyse M; Mineur L; Carola E; Etienne PL; Rivera F; Chirivella I; Perez-Staub N; Louvet C; André T; Tabah-Fisch I; de Gramont A
J Clin Oncol; 2006 Jan; 24(3):394-400. PubMed ID: 16421419
[TBL] [Abstract][Full Text] [Related]
31. Predictive role of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase expression in colorectal cancer patients receiving adjuvant 5-fluorouracil.
Ciaparrone M; Quirino M; Schinzari G; Zannoni G; Corsi DC; Vecchio FM; Cassano A; La Torre G; Barone C
Oncology; 2006; 70(5):366-77. PubMed ID: 17179731
[TBL] [Abstract][Full Text] [Related]
32. Prognostic value of ERCC1, thymidylate synthase, and glutathione S-transferase pi for 5-FU/oxaliplatin chemotherapy in advanced colorectal cancer.
Kim SH; Kwon HC; Oh SY; Lee DM; Lee S; Lee JH; Roh MS; Kim DC; Park KJ; Choi HJ; Kim HJ
Am J Clin Oncol; 2009 Feb; 32(1):38-43. PubMed ID: 19194123
[TBL] [Abstract][Full Text] [Related]
33. Safety and efficacy of modified FOLFOX6 for treatment of metastatic or locally advanced colorectal cancer. A single-institution outcome study.
Matsumoto S; Nishimura T; Kanai M; Mori Y; Nagayama S; Kawamura J; Nomura A; Miyamoto S; Kitano T; Ishiguro H; Yanagihara K; Teramukai S; Sakai Y; Chiba T; Fukushima M
Chemotherapy; 2008; 54(5):395-403. PubMed ID: 18781065
[TBL] [Abstract][Full Text] [Related]
34. Deleted in colon cancer protein expression in colorectal cancer metastases: a major predictor of survival in patients with unresectable metastatic disease receiving palliative fluorouracil-based chemotherapy.
Aschele C; Debernardis D; Lonardi S; Bandelloni R; Casazza S; Monfardini S; Gallo L
J Clin Oncol; 2004 Sep; 22(18):3758-65. PubMed ID: 15365072
[TBL] [Abstract][Full Text] [Related]
35. Oxidative and antioxidative status after anthracyclinebased chemotherapy in breast cancer patients.
Alacacioglu A; Kebapcilar L; Onder Pamuk B; Sop G; Kucukiravul C; Bozkaya G; Yuksel A; Alacacioglu I; Sari I
J BUON; 2013; 18(3):614-8. PubMed ID: 24065472
[TBL] [Abstract][Full Text] [Related]
36. Biochemical liver function test parameter levels in relation to treatment response in liver metastatic colorectal patients treated with FOLFOX4 with or without bevacizumab.
Denić K; Tarabar D; Obradovic S; Ristić M; Spasić J; Radosavljević D; Ugrešić N
Srp Arh Celok Lek; 2016; 144(11-12):615-20. PubMed ID: 29659222
[TBL] [Abstract][Full Text] [Related]
37. Fucosylated haptoglobin is a novel type of cancer biomarker linked to the prognosis after an operation in colorectal cancer.
Takeda Y; Shinzaki S; Okudo K; Moriwaki K; Murata K; Miyoshi E
Cancer; 2012 Jun; 118(12):3036-43. PubMed ID: 22006099
[TBL] [Abstract][Full Text] [Related]
38. Effects of 5-fluorouracil on oxidative stress and calcium levels in the blood of patients with newly diagnosed colorectal cancer.
Koçer M; Nazıroğlu M
Biol Trace Elem Res; 2013 Dec; 155(3):327-32. PubMed ID: 23990499
[TBL] [Abstract][Full Text] [Related]
39. Changes in the levels of thioredoxin and indoleamine-2,3-dioxygenase activity in plasma of patients with colorectal cancer treated with chemotherapy.
Cavia-Saiz M; Muñiz P; De Santiago R; Herreros-Villanueva M; Garcia-Giron C; Lopez AS; Coma-Del Corral MJ
Biochem Cell Biol; 2012 Apr; 90(2):173-8. PubMed ID: 22257103
[TBL] [Abstract][Full Text] [Related]
40. Lymphocytic enzymes and lipid peroxidation in patients with metabolic syndrome.
De Bona KS; Bonfanti G; Cargnelutti LO; Bitencourt PE; da Silva PS; Ceolin R; Pimentel VC; Moretto MB
Clin Biochem; 2012 Sep; 45(13-14):1081-5. PubMed ID: 22709933
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
